Worldwide variation in Pseudomonas associated ventilator associated pneumonia. A meta-regression
- PMID: 30771693
- DOI: 10.1016/j.jcrc.2019.02.001
Worldwide variation in Pseudomonas associated ventilator associated pneumonia. A meta-regression
Abstract
Purpose: The objective here is to define the extent and possible reasons for geographic variation in Pseudomonas aeruginosa associated with Ventilator Associated Pneumonia (VAP).
Methods: A random effects meta-regression model of Pseudomonas associated VAP incidence within the published literature was undertaken incorporating group level factors such trauma admission, year of publication and use of bronchoscopic sampling towards VAP diagnosis.
Results: Pseudomonas associated VAP incidence was reported in 162 studies from seven worldwide regions published over 30 years. The highest incidence is among reports from the Middle East and Mediterranean being respectively 6.8; 5.2-9.0 (mean; 95% CI) and 6.9; 5.4-8.8 per 1000 mechanical ventilation (MV) days, versus that from North American ICU's (3.7; 2.3-5.9). In a meta-regression model, the variation in the incidence of Pseudomonas associated VAP was not significantly associated with bronchoscopic sampling in the diagnosis of VAP (p = 0.12) nor with admission to a trauma ICU (p = 0.13).
Conclusion: Pseudomonas associated VAP incidence among reports from six geographic regions worldwide varies by less than twofold with some decline by year of publication. Trauma ICU admission is a significant factor underlying variations in incidence of VAP overall but not Pseudomonas associated VAP.
Keywords: Geographic variation; Intensive care unit; Pseudomonas aeruginosa; Ventilator associated pneumonia.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression.BMC Infect Dis. 2016 Oct 18;16(1):577. doi: 10.1186/s12879-016-1921-4. BMC Infect Dis. 2016. PMID: 27756238 Free PMC article.
-
World-Wide Variation in Incidence of Staphylococcus aureus Associated Ventilator-Associated Pneumonia: A Meta-Regression.Microorganisms. 2018 Feb 27;6(1):18. doi: 10.3390/microorganisms6010018. Microorganisms. 2018. PMID: 29495472 Free PMC article.
-
Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3. Trials. 2017. PMID: 28114979 Free PMC article. Clinical Trial.
-
Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study.Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):1999-2006. doi: 10.1007/s10096-016-2703-z. Epub 2016 Jun 10. Eur J Clin Microbiol Infect Dis. 2017. PMID: 27287765 Review.
-
Ventilator-associated pneumonia.Semin Respir Crit Care Med. 2014 Aug;35(4):469-81. doi: 10.1055/s-0034-1384752. Epub 2014 Aug 11. Semin Respir Crit Care Med. 2014. PMID: 25111643 Review.
Cited by
-
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.Intensive Care Med. 2022 Jul;48(7):841-849. doi: 10.1007/s00134-022-06690-5. Epub 2022 May 13. Intensive Care Med. 2022. PMID: 35552788 Clinical Trial.
-
Candida-Acinetobacter-Pseudomonas Interaction Modelled within 286 ICU Infection Prevention Studies.J Fungi (Basel). 2020 Oct 27;6(4):252. doi: 10.3390/jof6040252. J Fungi (Basel). 2020. PMID: 33121074 Free PMC article.
-
Estimating the herd effects of anti-microbial-based decontamination (ABD) interventions on intensive care unit (ICU) acquired bloodstream infections: a deductive meta-analysis.BMJ Open. 2024 Nov 20;14(11):e092030. doi: 10.1136/bmjopen-2024-092030. BMJ Open. 2024. PMID: 39572099 Free PMC article.
-
Associations Between Candida and Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter Species as Ventilator-Associated Pneumonia Isolates in 84 Cohorts of ICU Patients.Microorganisms. 2025 May 22;13(6):1181. doi: 10.3390/microorganisms13061181. Microorganisms. 2025. PMID: 40572069 Free PMC article.
-
Analyzing Clinical Parameters and Bacterial Profiles to Uncover the COPD Exacerbations: A Focus on Intensive Care Unit Challenges.Medicina (Kaunas). 2025 Apr 5;61(4):669. doi: 10.3390/medicina61040669. Medicina (Kaunas). 2025. PMID: 40282960 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources